Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis

Published:2024-08-20 Issue:1 Volume:47 Page:
ISSN:1437-2320
Container-title:Neurosurgical Review
language:en
Short-container-title:Neurosurg Rev

Author:

Habibi Mohammad Amin^ORCID,Shad Niloufar^ORCID,Mirjnani Mohammad Sina^ORCID,Fasihi Sara^ORCID,Sadeghi Sara^ORCID,Karami Shaghayegh^ORCID,Ahmadvand Muhammad Hussain,Delbari Pouria^ORCID,Zare Amir Hossein^ORCID,Zare Amir Hessam,Alavi Seyed Ahmad Naseri

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10143-024-02667-8.pdf

Reference60 articles.

1. Schwartzbaum JA et al (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9):494–503 quiz 1 p following 516

2. Hanif F et al (2017) Glioblastoma Multiforme: a review of its epidemiology and Pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 18(1):3–9

3. Li T et al (2022) Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions. J Control Release 352:338–370

4. Salari N et al (2023) The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis. Eur J Med Res 28(1):39

5. Darvishi M et al (2024) P104: a single-center perspective on glioma epidemiology from 2018–2023 in the Middle East. Genet Med Open, 2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP